Chymotrypsin

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert, Linda Cavaletti

Retrieved on: 
Friday, April 23, 2021
Peptidase, Trypsin, Endopeptidase, Cavaletti, Chymotrypsin

I look forward to working with the team over the coming years to build a broad-based, world-class company.

Key Points: 
  • I look forward to working with the team over the coming years to build a broad-based, world-class company.
  • "\n"I am personally very pleased to welcome such an outstanding scientist as an advisor to Nemysis," said Danilo Casadei-Massari, Chairman of the Board.
  • "No doubt Linda Cavaletti\'s expertise will contribute to increasing the value of Nemysis\'s current and future assets.
  • Safety and efficacy have been demonstrated in controlled-repeat-dose clinical trials.\nNemysis\'s novel E40 endopeptidase is gastric, trypsin and chymotrypsin resistant.